Shield Therapeutics PLC
LSE:STX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shield Therapeutics PLC
LSE:STX
|
UK |
|
Packaging Corp of America
NYSE:PKG
|
US |
|
CNB Financial Corp
F:44I
|
US |
|
RMR Group Inc
NASDAQ:RMR
|
US |
|
L
|
Ls Invest AG
XHAM:IFA
|
DE |
|
Taseko Mines Ltd
TSX:TKO
|
CA |
|
A
|
Aspermont Ltd
ASX:ASP
|
AU |
|
Inventiva SA
F:6IVA
|
FR |
|
Target Hospitality Corp
NASDAQ:TH
|
US |
|
Semen Baturaja (Persero) Tbk PT
IDX:SMBR
|
ID |
|
Inter & Co Inc
F:QN7
|
BR |
|
Multi Commodity Exchange of India Ltd
NSE:MCX
|
IN |
|
K
|
Komputronik SA w restrukturyzacji
WSE:KOM
|
PL |
Wall St Price Targets
STX Price Targets Summary
Shield Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for STX is 15.3 GBX with a low forecast of 12.12 GBX and a high forecast of 24.15 GBX.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is STX's stock price target?
Price Target
15.3
GBX
According to Wall Street analysts, the average 1-year price target for STX is 15.3 GBX with a low forecast of 12.12 GBX and a high forecast of 24.15 GBX.
What is the Revenue forecast for Shield Therapeutics PLC?
Projected CAGR
28%
The compound annual growth rate for Revenue over the next 6 years is 28%.
What is the Gross Profit forecast for Shield Therapeutics PLC?
Projected CAGR
32%
The compound annual growth rate for Gross Profit over the next 6 years is 32%.